The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Enemy at the Gates: The Emerging Threat of COVID-19

Enemy at the Gates: The Emerging Threat of COVID-19

March 23, 2020 • By Philip Seo

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Philip Seo, MD, MHS

On Dec. 30, 2019, an ophthalmologist named Li Wenliang notified his colleagues about an illness that was reminiscent of severe acute respiratory syndrome (SARS) in a city in the Hubei province of China called Wuhan. As an ophthalmologist, this was not directly relevant to his practice; he merely wanted to warn colleagues that they might want to be more careful about contact precautions. Soon afterward, the Wuhan Public Security Bureau forced him to sign a statement recanting the warning and admitting he had made a false statement to disturb public order.

You Might Also Like
  • Respiratory Failure More Common in COVID-19 Patients with Rheumatic Disease
  • U.S. to Tell Doctors to Report Cases of COVID-19 Inflammatory Syndrome in Kids
  • Regulatory Backlog in Emerging Nations Adding Years to Drug Approvals
Explore This Issue
April 2020
Also By This Author
  • The Half-Life of the Truth

By that time, however, it was too late. You have, by now, heard the oft-repeated phrase that COVID-19 is apolitical. Despite multiple press releases insisting that COVID-19 would die out, the virus has spread like the wildfires that affected California and Australia in 2019.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

By March 11, 2020, the World Health Organization (WHO) announced that it was classifying COVID-19 as a pandemic. This is the first time the WHO has declared a pandemic since the H1N1 swine flu in 2009. This extraordinary action reflects the extraordinary speed with which COVID-19 has spread worldwide. At the time of this writing, COVID-19 has been reported in 114 countries and killed more than 4,000 people; by the time you read this, these numbers will have increased.

On March 13, President Trump declared the pandemic a national emergency.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The Johns Hopkins Center for Systems Science and Engineering is tracking cases of COVID-19 in real time. These data are being shared in an interactive, web-based dashboard that is updated every 15 minutes, using data from the China CDC (CDCC), Hong Kong Department of Health, Macau Government, Taiwan CDC, European CDC (ECDC), the World Health Organization (WHO), the U.S. Centers for Disease Control & Prevention (CDC), the Government of Canada, and the Australian Government Department of Health. The dashboard also incorporates reports from local municipalities and organizations, most prominently, DXY, a crowdsourced platform run by the Chinese medical community.

According to the Johns Hopkins Coronavirus Resource Center, more than 322,000 cases of COVID-19 have been confirmed worldwide (as of 3/22/2020). The highest number of cases have been reported in China (81,397), Italy (53,578), the U.S.(30,285), Spain (28,603) and Germany (23,974). All 50 states have reported at least one case of COVID-19; West Virginia was the last to fall, on March 17.

All of these numbers, of course, are wrong; they reflect the number of identified cases and do not take into account the large number of patients who will never be identified, either because they were minimally symptomatic or they were never tested.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Conditions, Professional Topics, Rheuminations Tagged With: COVID-19, Philip Seo, Rheuminations, SeoIssue: April 2020

You Might Also Like:
  • Respiratory Failure More Common in COVID-19 Patients with Rheumatic Disease
  • U.S. to Tell Doctors to Report Cases of COVID-19 Inflammatory Syndrome in Kids
  • Regulatory Backlog in Emerging Nations Adding Years to Drug Approvals
  • The COVID-19 Pandemic: What You Should Know

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.